Oxford Biomedica plc (OTCMKTS:OXBDF - Get Free Report)'s stock price rose 18.7% during trading on Thursday . The company traded as high as $4.66 and last traded at $4.66. Approximately 550 shares were traded during trading, a decline of 96% from the average daily volume of 12,757 shares. The stock had previously closed at $3.93.
Oxford Biomedica Price Performance
The company has a debt-to-equity ratio of 1.48, a quick ratio of 2.07 and a current ratio of 2.35. The company's 50 day moving average price is $3.81 and its two-hundred day moving average price is $4.51.
Oxford Biomedica Company Profile
(
Get Free Report)
Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.
Featured Stories
Before you consider Oxford BioMedica, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oxford BioMedica wasn't on the list.
While Oxford BioMedica currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.